Clinical features | Case | RAD52 positive rate (%; mean ± SD) | P-value |
---|---|---|---|
Sample | |||
 HCC | 70 | 65.600 ± 25.079 | P < 0.05* |
 Adjacent tissue | 70 | 48.057 ± 26.928 |  |
Age (years) | |||
 ≤ 45 | 28 | 57.036 ± 28.299 | P < 0.05* |
 > 45 | 42 | 71.310 ± 21.157 |  |
Gender | |||
 Male | 61 | 66.918 ± 24.841 | P > 0.05 |
 Female | 9 | 56.667 ± 26.339 |  |
Smoking | |||
 Yes | 35 | 63.486 ± 26.579 | P > 0.05 |
 No | 35 | 67.714 ± 23.681 |  |
Drinking | |||
 Yes | 38 | 65.316 ± 26.366 | P > 0.05 |
 No | 32 | 65.938 ± 23.876 |  |
HBsAg infection | |||
 Yes | 50 | 68.700 ± 25.948 | P > 0.05 |
 No | 20 | 57.850 ± 21.431 |  |
AFP (ng/ml) | |||
 ≤ 20 | 20 | 66.100 ± 21.885 | P > 0.05 |
 > 20 | 50 | 65.400 ± 26.454 |  |
Tumor size (cm) | |||
 ≤ 5 | 12 | 53.750 ± 23.848 | P > 0.05 |
 > 5 | 6 | 45.000 ± 32.711 |  |
 Unknown | 52 | 70.712 ± 22.667 |  |
Clinical stage | |||
 I + II | 32 | 63.656 ± 25.299 | P > 0.05 |
 III + IV | 38 | 67.237 ± 25.113 |  |
ALT | |||
 ≤ 40 | 38 | 64.083 ± 27.055 | P > 0.05 |
 > 40 | 32 | 70.517 ± 22.494 |  |
AST | |||
 ≤ 40 | 28 | 65.280 ± 25.370 | P > 0.05 |
 > 40 | 42 | 68.000 ± 25.263 |  |